Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Amiodarone hydrochloride 200 mg tablets
The George Institute
Persistent atrial fibrillation
1 trial -
Amlodipine besylate
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Amlodipine besylate/atorvastatin calcium single pill combination
Pfizer
Hypertension
1 trial -
Amodiaquine plus Artesunate co-administration
United Therapeutics Europe Ltd
Malaria
1 trial -
Amoxicilina/Ácido clavulánico NORMON 1.000 mg/200 mg polvo para solución inyectable y para perfusión EFG, Amoxicilina/Ácido clavulánico NORMON 875 mg/125 mg comprimidos recubiertos con película EFG
The George Institute
Complicated acute appendicitis
1 trial -
Amoxicillin 500 mg film-coated tablets, Placebo amoxicillin capsules 500mg
Disc Medicine
non-specific low back pain
1 trial -
Amoxicillin/clavulanate
GlaxoSmithKline
Focal Infection, Dental
1 trial -
Anti-Arrhythmics
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmia, Cardiac
1 trial -
Anti-Platelet Drugs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unstable Angina
3 trials -
Anti-hypertensive therapy
Arrowhead Pharmaceuticals Ireland Limited
Hypertension
1 trial -
Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
Takeda
Hemophilia A
4 trials -
Apixaban
Pfizer
Atrial Fibrillation
1 trial -
Arctic Front Advance Cardiac CryoAblation system
Rhythm Pharmaceuticals Netherlands B.V.
Paroxysmal Atrial Fibrillation
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Aripiprazole
United Therapeutics Europe Ltd
Hyperprolactinemia
1 trial -
Artemether-lumefantrine combination
United Therapeutics Europe Ltd
Plasmodium Vivax Infection
1 trial -
Artesunate-amodiaquine combination
United Therapeutics Europe Ltd
Malaria,Falciparum
1 trial -
Atezolizumab
Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
1 trial -
Atorvastatin 20mg
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Avamys aqueous nasal spray 110mcg
GlaxoSmithKline
Rhinitis, Allergic, Perennial
1 trial -
Avapritinib, Avapritinib
Blueprint Medicines (Netherlands) B.V.
Systemic Mastocytosis
1 trial -
BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM
Lacuna Pharma Pty Ltd
Respiratory Tract Infections with Wheezing Lower Respiratory Illness
1 trial -
Babaodan oral capsule
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Bacillus Clausii Multi ATB Resist
Sanofi Pasteur
Diarrhea, Infantile
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources